Rezolute logo

Rezolute

RZLTNASDAQ

Rezolute is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Nevan Charles Elam, with a market cap of $338.8M.

Market Cap$338.8M
Employees51.0
CEONevan Charles Elam
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · In 3 weeksAfter Market Close · Q3 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
Rezolute logo

Rezolute FAQ

Common questions about Rezolute

Rezolute is scheduled to report earnings for Q3 2026 on May 12, 2026 after market close.

Rezolute has approximately 51 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.